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Abstract
Invasive Salmonella infection is an important health problem that is worsening because of rising antimicrobial resistance
and changing Salmonella serovar spectrum. Novel vaccines with broad serovar coverage are needed, but suitable protective
antigens remain largely unknown. Here, we tested 37 broadly conserved Salmonella antigens in a mouse typhoid fever
model, and identified antigen candidates that conferred partial protection against lethal disease. Antigen properties such as
high in vivo abundance or immunodominance in convalescent individuals were not required for protectivity, but all
promising antigen candidates were associated with the Salmonella surface. Surprisingly, this was not due to superior
immunogenicity of surface antigens compared to internal antigens as had been suggested by previous studies and novel
findings for CD4 T cell responses to model antigens. Confocal microscopy of infected tissues revealed that many live
Salmonella resided alone in infected host macrophages with no damaged Salmonella releasing internal antigens in their
vicinity. In the absence of accessible internal antigens, detection of these infected cells might require CD4 T cell recognition
of Salmonella surface-associated antigens that could be processed and presented even from intact Salmonella. In
conclusion, our findings might pave the way for development of an efficacious Salmonella vaccine with broad serovar
coverage, and suggest a similar crucial role of surface antigens for immunity to both extracellular and intracellular
pathogens.
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Introduction
Enteric fever caused by systemic Salmonella infection causes
tremendous morbidity and mortality worldwide [1]. Current
control strategies become increasingly inefficient as a result of
increasing antimicrobial resistance [2,3] and emergence of
Salmonella serovars that are not covered by currently available safe
vaccines [4,5]. This situation generates an urgent medical need for
novel Salmonella vaccines with broad serovar coverage.
Early killed whole-cell vaccines containing mixtures of different
serovars provide broad protection, but cause unacceptable adverse
reactions [1]. As an alternative to whole-cell vaccines, subunit
vaccines containing a few defined Salmonella components could
minimize adverse reactions. Indeed, vaccines containing the
capsular polysaccharide Vi antigen provide moderate protection
and excellent safety [1]. On the other hand, serovars Paratyphi A
and non-typhoidal Salmonella (NTS) that cause an increasing
number of invasive salmonelloses [6], lack the Vi antigen and are
therefore not covered by Vi vaccines [5]. Apart from Vi, few
Salmonella antigens have been identified, and all of these provide at
best moderate levels of protection against challenge infection with
virulent Salmonella strains in the commonly used mouse typhoid
fever model. Moreover, antigens such as flagellin [7] and OmpD
[8] are poorly conserved among relevant serovars.
For extracellular pathogens with antibody-mediated immunity,
protective antigens must be surface-exposed [9], and this enables
an effective strategy for priorization of antigen candidates [9].
Humoral response to surface antigens can also contribute to
immunity to intracellular pathogens such as invasive Salmonella
[10]. Indeed, Vi which induces protective antibody responses in
human vaccinees, forms an extracellular capsule around Salmonella
Typhi [11]. Two additional antigens that confer partial immunity
in the mouse typhoid fever model, flagellin [7] and SseB [12], are
also part of Salmonella surface structures (flagella, translocon
complex of a type III secretion system). Furthermore, outer
membrane preparations (but not the outer membrane component
lipopolysaccharide) have been suggested to mediate protective
humoral immune responses against extracellular Salmonella bac-
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teremia [13] and attenuated Salmonella strains in the mouse model
[8,14]. A number of porins such as OmpC, OmpD, and OmpF
are highly abundant in such outer membrane preparations
suggesting that they might represent the actual protective antigens
[8,14,15].
However, immunity to Salmonella critically depends also on CD4
T cells [10]. Unfortunately, protective T cell antigens seem to be
rare, and priorization of candidates is difficult since relevant
antigen properties for CD4 T cell responses remain unclear
[9,16,17]. One key precondition for protective responses is
expression of the respective Salmonella antigen during infection
[18], and some data suggest that highly abundant antigens might
be particularly well recognized by CD4 T cells [12,19]. Antigen in
vivo expression can be deduced from various complementary
approaches including screening of promoter trap libraries [20,21],
proteomics [22], serum antibody response [23–26], as well as
mutant virulence phenotypes.
In addition to antigen expression, antigen immunogenicity
could play a major role. Antigen detection by cognate CD4 T cells
requires antigen processing and presentation of the resulting small
peptides by major histocompatibility (MHC) class II molecules.
Peptide sequence properties that are characteristic for well
recognized epitopes, can be used for genome-wide prediction of
promising antigens [27]. However, a large number of non-
protective antigens contain putative high-score epitopes [16,18,28]
which could compromise the discriminatory power of this
approach.
Experimental detection of immune responses to an antigen in
convalescent individuals that have survived infection, demon-
strates that this antigen was expressed in vivo and could be
recognized by the immune system [23–25]. Indeed, this approach
has been recently shown to facilitate identification of protective
Chlamydia antigens [29]. On the other hand, many immunodomi-
nant antigens in convalescent individuals lack protective efficacy,
while a number of protective antigens may induce immune
responses below the detection threshold during natural infection
[17].
Another antigen property that can affect CD4 T cell responses
is antigen localization. In particular, secreted or surface-associated
antigens might induce particularly strong cellular immune
responses because of superior processing, kinetic advantages
compared to internal antigens, and/or physical association with
pathogen-associated molecular patterns (PAMP) such as lipopoly-
saccharide that provide potent stimuli for innate and adaptive
immunity [14,30–36]. Indeed, secretion/surface localization has
been widely used to prioritize candidates for antigen identification.
However, antigens with likely internal localization can also induce
specific CD4 T cell responses that mediate protection against
various intracellular pathogens [37,38].
Taken together, relevant antigen properties for CD4 T cell
mediated immunity to intracellular pathogens remain poorly
characterized, and this impairs antigen priorization for vaccine
development. To address this issue, we compared here 37 diverse
Salmonella antigens in a mouse model that closely mimics human
typhoid fever [39]. The results suggested that recognition of
surface-associated antigens might be necessary to detect and
combat live intracellular Salmonella, whereas recognition of internal
antigens would mediate futile non-protective attack of already
dead Salmonella. In conclusion, we propose a similar crucial role of
surface-associated antigens for immunity to both extracellular and
intracellular pathogens.
Results
Immune responses to Salmonella antigens in
convalescent individuals
To determine immune responses to Salmonella antigens, we
selected 21 broadly conserved Salmonella proteins. We selected
several subunits of the SPI-2 type III secretion system since the
putative translocon subunit SseB of this system showed promising
protectivity in previous studies [12,26]. We also included several
porins since a previous study had shown that OmpD conferred
protection against an attenuated Salmonella mutant [8]. To explore
the role of antigen localization we selected additional proteins
localized in Salmonella cytosol, inner membrane, periplasm, and
outer membrane/surface. To explore the role of antigen
abundance, we determined absolute quantities of more than
1100 Salmonella in infected mouse spleen. Specifically, we purified
Salmonella from infected mouse spleen using flow cytometry as
described [22]. We determined absolute protein quantities in these
ex vivo purified Salmonella using shot-gun proteomics with 30
isotope labeled reference peptides and the iBAQ quantification
method [40] (for detailed description see Materials and Methods
section). From these data, we selected additional antigens with a
large range of abundances (Tab. 1).
To determine potential cross-protection between different
serovars, we cloned the corresponding genes from Salmonella
enterica serovar Typhi (except for OmpD which was obtained from
serovar Typhimurium since it is absent in serovar Typhi). We
expressed the proteins as C-terminal His6-fusions in E. coli
followed by Ni-affinity chromatography purification. We purified
the control antigen GFP-His6 using the same protocol.
We determined immune responses to these antigens in
genetically resistant, convalescent mice that had survived infection
with virulent Salmonella enterica serovar Typhimurium. We detected
antigen-specific CD4 T cells in spleen using a sensitive CD154
assay [41] and measured serum IgG antibody responses using
ELISA. All tested antigens were recognized by CD4 T cells
(Fig. 1A; Tab. 1), many of which secreted IFNc or IL-17 upon
stimulation. Both cytokines play crucial roles in immunity to
Salmonella [10]. Frequencies of responsive CD4 T cells were in the
same range as for flagellin, which has been considered an
immunodominant antigen [42]. These data suggested that
Salmonella infection elicited a broad cellular immune response
Author Summary
Salmonella infections cause extensive morbidity and
mortality worldwide. A vaccine that prevents systemic
Salmonella infections is urgently needed but suitable
antigens remain largely unknown. In this study we
identified several antigen candidates that mediated
protective immunity to Salmonella in a mouse typhoid
fever model. Interestingly, all these antigens were associ-
ated with the Salmonella surface. This suggested that
similar antigen properties might be relevant for CD4 T cell
dependent immunity to intracellular pathogens like
Salmonella, as for antibody-dependent immunity to
extracellular pathogens. Detailed analysis revealed that
Salmonella surface antigens were not generally more
immunogenic compared to internal antigens. However,
internal antigens were inaccessible for CD4 T cell recog-
nition of a substantial number of infected host cells that
contained exclusively live intact Salmonella. Together,
these results might pave the way for development of an
efficacious Salmonella vaccine, and provide a basis to
facilitate antigen identification for Salmonella and possibly
other intracellular pathogens.
Identification of Salmonella Vaccine Antigens
PLOS Pathogens | www.plospathogens.org 2 October 2012 | Volume 8 | Issue 10 | e1002966
T
a
b
le
1
.
P
ro
p
e
rt
ie
s
o
f
Sa
lm
o
n
el
la
an
ti
g
e
n
s.
S
T
Y
a
n
ti
g
e
n
S
T
m
o
rt
h
o
lo
g
u
e
N
a
m
e
C
o
m
p
a
rt
m
e
n
t
In
v
iv
o
a
b
u
n
d
a
n
ce
in
co
p
ie
s
p
e
r
ce
ll
±
S
E
M
C
D
1
5
4
+
ce
ll
s
p
e
r
1
0
6
C
D
4
T
ce
ll
s
±
S
E
M
P
-
v
a
lu
e
1
IF
N
g
-s
e
cr
e
ti
n
g
ce
ll
s
p
e
r
1
0
6
C
D
4
T
ce
ll
s
±
S
E
M
P
-
v
a
lu
e
1
IL
1
7
-s
e
cr
e
ti
n
g
ce
ll
s
p
e
r
1
0
6
C
D
4
T
ce
ll
s
±
S
E
M
P
-
v
a
lu
e
1
S
e
ru
m
Ig
G
in
n
g
m
l2
1
±
S
E
M
P
-
v
a
lu
e
2
S
u
rv
iv
a
l
ti
m
e
e
x
te
n
si
o
n
in
d
a
y
s
P
-
v
a
lu
e
3
T
2
4
6
1
ST
M
0
4
0
2
C
yt
o
so
l
2
1
7
2
5
6
2
8
3
7
1
9
4
9
6
7
3
3
0
.0
0
8
5
9
1
6
2
5
1
0
.0
1
4
2
6
8
6
8
2
0
.0
0
5
3
4
0
6
6
1
8
5
2
,
0
.0
0
1
2
3
0
.9
2
4
T
1
6
8
9
ST
M
1
2
3
1
p
h
o
P
C
yt
o
so
l
2
4
0
6
0
6
1
4
1
0
9
3
8
6
2
9
5
0
.0
0
9
2
2
1
6
4
5
0
.0
0
1
1
4
0
6
5
3
0
.0
1
2
8
5
6
2
0
0
.0
4
5
2
1
0
.7
0
2
T
1
2
6
5
ST
M
1
3
9
7
ss
eA
C
yt
o
so
l
2
1
6
3
6
8
7
7
7
0
3
6
2
4
5
0
.0
3
0
1
3
7
6
1
7
0
.0
0
1
8
4
6
2
0
0
.0
0
2
3
6
6
7
0
.3
1
0
2
3
0
.6
3
9
T
0
7
8
2
ST
M
2
0
9
0
rf
b
H
C
yt
o
so
l
4
2
6
0
6
3
9
2
1
0
3
5
6
4
8
1
0
.0
1
9
2
7
0
6
1
4
0
0
.0
3
0
1
7
0
6
5
6
0
.0
0
8
7
9
6
1
9
,
0
.0
0
1
2
3
0
.5
5
5
T
0
5
2
4
ST
M
2
3
4
0
C
yt
o
so
l
9
2
2
6
4
3
4
9
2
3
6
5
2
0
0
.0
3
8
2
7
6
6
1
1
9
0
.0
2
0
1
0
3
6
3
0
0
.0
0
9
3
6
6
0
,
0
.0
0
1
2
1
0
.7
8
2
T
3
0
5
3
ST
M
3
1
3
2
C
yt
o
so
l
7
5
0
4
6
1
3
7
4
1
0
8
3
6
6
1
8
0
.0
3
0
3
2
2
6
9
8
0
.0
0
9
1
9
8
6
7
1
0
.0
1
6
5
2
6
1
0
,
0
.0
0
1
2
2
0
.6
7
6
T
3
5
9
5
ST
M
4
0
2
6
yi
h
X
C
yt
o
so
l
5
1
0
1
6
9
0
2
1
0
1
4
6
6
2
1
0
.1
1
9
2
0
6
6
8
5
0
.0
4
4
1
0
0
6
4
2
0
.0
4
5
4
2
6
9
0
.2
8
7
0
0
.1
4
6
T
1
5
0
6
ST
M
1
5
9
7
yd
cW
C
yt
o
so
l
2
3
2
8
6
4
6
2
9
5
2
6
6
5
2
0
.3
7
8
1
3
9
6
6
6
0
.0
3
0
1
0
6
6
6
5
0
.0
2
2
4
6
6
9
0
.0
0
6
3
0
.2
6
8
T
2
7
6
3
ST
M
2
8
6
1
si
tA
In
n
e
r
M
e
m
b
ra
n
e
6
4
4
6
1
3
6
8
7
3
6
3
9
9
0
.0
2
4
8
7
6
2
7
0
.1
2
6
7
6
6
4
5
0
.0
4
3
5
2
6
2
9
0
.0
1
1
2
4
0
.9
3
8
T
3
8
7
2
ST
M
3
6
4
7
yi
a
F
In
n
e
r
M
e
m
b
ra
n
e
8
2
9
6
3
5
4
n
.d
.
n
.d
.
n
.d
.
n
.d
.
0
0
.8
8
0
T
1
5
0
8
ST
M
1
5
9
9
p
cg
L
P
e
ri
p
la
sm
1
4
6
0
5
6
2
1
3
5
5
0
3
6
2
3
5
0
.0
7
7
7
5
6
2
2
0
.0
0
6
6
3
6
6
6
0
.1
1
0
1
2
1
2
6
9
4
0
,
0
.0
0
1
2
3
0
.8
6
8
T
0
3
0
0
ST
M
2
5
5
6
h
m
p
A
P
e
ri
p
la
sm
7
6
5
8
6
1
1
5
4
8
5
3
6
4
8
4
0
.0
4
3
3
0
2
6
2
1
6
0
.0
8
8
1
2
5
6
7
4
0
.0
4
5
3
8
6
1
,
0
.0
0
1
2
1
0
.3
9
8
T
4
2
2
5
ST
M
4
3
1
9
p
h
o
N
P
e
ri
p
la
sm
3
7
6
0
6
6
2
7
4
2
5
5
9
6
2
6
3
0
.0
2
1
1
5
5
6
3
9
0
.0
0
4
5
9
6
3
0
0
.0
3
8
2
8
9
1
6
7
6
0
,
0
.0
0
1
2
1
0
.7
6
1
T
2
4
1
5
ST
M
0
4
4
5
ya
jG
Li
p
o
p
ro
te
in
(o
u
te
r
m
e
m
b
ra
n
e
)
1
0
5
7
6
3
6
0
n
.d
.
n
.d
.
n
.d
.
n
.d
.
2
2
0
.6
9
0
T
1
0
5
8
ST
M
1
8
1
9
sl
p
Li
p
o
p
ro
te
in
(o
u
te
r
m
e
m
b
ra
n
e
)
5
9
9
6
2
0
8
n
.d
.
n
.d
.
n
.d
.
n
.d
.
2
1
0
.8
3
5
T
3
1
9
9
ST
M
3
2
8
1
n
lp
L
Li
p
o
p
ro
te
in
(o
u
te
r
m
e
m
b
ra
n
e
)
b
.t
n
.d
.
n
.d
.
n
.d
.
n
.d
.
2
1
0
.4
1
8
T
0
3
7
1
ST
M
2
4
8
8
n
lp
B
Li
p
o
p
ro
te
in
(o
u
te
r
m
e
m
b
ra
n
e
)
2
5
9
3
6
3
6
3
n
.d
.
n
.d
.
n
.d
.
n
.d
.
1
0
.9
2
1
T
0
3
3
6
ST
M
2
5
2
0
yf
g
L
Li
p
o
p
ro
te
in
(o
u
te
r
m
e
m
b
ra
n
e
)
2
1
3
1
6
2
8
6
n
.d
.
n
.d
.
n
.d
.
n
.d
.
2
0
.3
8
6
T
2
6
1
9
ST
M
2
6
6
3
yf
iO
Li
p
o
p
ro
te
in
(o
u
te
r
m
e
m
b
ra
n
e
)
7
6
3
6
2
8
9
n
.d
.
n
.d
.
n
.d
.
n
.d
.
4
0
.4
4
1
T
1
4
5
9
ST
M
1
5
4
0
Li
p
o
p
ro
te
in
(o
u
te
r
m
e
m
b
ra
n
e
)
5
4
8
5
6
6
9
4
n
.d
.
n
.d
.
n
.d
.
n
.d
.
6
0
.1
5
0
T
3
8
7
4
ST
M
3
6
4
5
yi
a
D
Li
p
o
p
ro
te
in
(o
u
te
r
m
e
m
b
ra
n
e
)
3
8
5
6
6
8
5
9
n
.d
.
n
.d
.
n
.d
.
n
.d
.
8
0
.1
9
6
T
0
9
3
7
ST
M
1
9
4
0
Li
p
o
p
ro
te
in
(o
u
te
r
m
e
m
b
ra
n
e
)
1
8
6
4
6
3
9
6
5
4
6
6
6
5
0
0
.1
2
8
6
7
6
8
9
0
.1
4
0
4
9
6
2
5
0
.0
1
3
3
7
6
2
,
0
.0
0
1
9
0
.0
2
3
T
1
3
1
3
ST
M
1
4
4
5
sl
yB
Li
p
o
p
ro
te
in
(o
u
te
r
m
e
m
b
ra
n
e
)
7
2
7
0
6
7
1
9
n
.d
.
n
.d
.
n
.d
.
n
.d
.
1
2
0
.2
2
8
T
1
2
6
2
ST
M
1
3
9
4
ss
a
C
O
u
te
r
m
e
m
b
ra
n
e
b
.t
6
1
8
6
3
7
8
0
.0
7
3
1
1
4
6
3
6
0
.0
0
7
7
4
6
4
7
0
.0
6
2
3
5
6
1
,
0
.0
0
1
2
3
0
.2
4
0
T
3
1
0
7
ST
M
3
1
8
6
to
lC
O
u
te
r
m
e
m
b
ra
n
e
b
.t
8
9
8
6
5
5
0
0
.0
5
0
2
4
6
3
2
0
.2
7
3
7
9
6
4
4
0
.0
4
2
5
2
7
6
4
4
6
,
0
.0
0
1
2
3
0
.3
7
0
T
0
4
6
3
ST
M
2
3
9
5
p
g
tE
O
u
te
r
m
e
m
b
ra
n
e
8
4
6
6
6
1
0
3
2
1
9
2
4
6
5
8
3
0
.0
4
4
7
6
8
6
2
0
8
0
.0
1
6
2
4
5
6
1
0
9
0
.0
5
7
8
0
6
2
3
,
0
.0
0
1
2
1
0
.2
1
4
T
1
1
1
9
ST
M
1
2
4
6
p
a
g
C
O
u
te
r
m
e
m
b
ra
n
e
1
1
9
9
3
6
3
6
6
7
8
5
1
6
1
2
2
0
.0
0
9
2
7
3
6
7
9
0
.0
0
2
1
1
0
6
1
3
0
.0
0
1
3
6
6
1
,
0
.0
0
1
2
1
0
.4
7
8
Identification of Salmonella Vaccine Antigens
PLOS Pathogens | www.plospathogens.org 3 October 2012 | Volume 8 | Issue 10 | e1002966
T
a
b
le
1
.
C
o
n
t.
S
T
Y
a
n
ti
g
e
n
S
T
m
o
rt
h
o
lo
g
u
e
N
a
m
e
C
o
m
p
a
rt
m
e
n
t
In
v
iv
o
a
b
u
n
d
a
n
ce
in
co
p
ie
s
p
e
r
ce
ll
±
S
E
M
C
D
1
5
4
+
ce
ll
s
p
e
r
1
0
6
C
D
4
T
ce
ll
s
±
S
E
M
P
-
v
a
lu
e
1
IF
N
g
-s
e
cr
e
ti
n
g
ce
ll
s
p
e
r
1
0
6
C
D
4
T
ce
ll
s
±
S
E
M
P
-
v
a
lu
e
1
IL
1
7
-s
e
cr
e
ti
n
g
ce
ll
s
p
e
r
1
0
6
C
D
4
T
ce
ll
s
±
S
E
M
P
-
v
a
lu
e
1
S
e
ru
m
Ig
G
in
n
g
m
l2
1
±
S
E
M
P
-
v
a
lu
e
2
S
u
rv
iv
a
l
ti
m
e
e
x
te
n
si
o
n
in
d
a
y
s
P
-
v
a
lu
e
3
–
ST
M
1
5
7
2
o
m
p
D
O
u
te
r
m
e
m
b
ra
n
e
b
.t
n
.d
.
n
.d
.
n
.d
.
n
.d
.
2
1
0
.9
5
8
T
2
4
5
0
ST
M
0
4
1
3
ts
x
O
u
te
r
m
e
m
b
ra
n
e
6
8
3
5
6
5
1
0
n
.d
.
n
.d
.
n
.d
.
n
.d
.
0
0
.9
1
0
T
0
5
9
7
ST
M
2
2
6
7
o
m
p
C
O
u
te
r
m
e
m
b
ra
n
e
1
4
6
6
8
1
n
.d
.
n
.d
.
n
.d
.
n
.d
.
0
0
.5
4
0
T
0
2
2
5
ST
M
0
2
2
4
ya
eT
O
u
te
r
m
e
m
b
ra
n
e
1
8
3
5
6
2
3
3
n
.d
.
n
.d
.
n
.d
.
n
.d
.
1
0
.4
7
9
T
1
9
3
5
ST
M
0
9
9
9
o
m
p
F
O
u
te
r
m
e
m
b
ra
n
e
b
.t
n
.d
.
n
.d
.
n
.d
.
n
.d
.
1
0
.2
3
1
T
2
2
8
3
ST
M
0
5
8
5
fe
p
A
O
u
te
r
m
e
m
b
ra
n
e
b
.t
n
.d
.
n
.d
.
n
.d
.
n
.d
.
7
0
.3
4
4
T
2
6
7
2
ST
M
2
7
7
7
ir
o
N
O
u
te
r
m
e
m
b
ra
n
e
b
.t
1
0
3
8
6
5
6
9
0
.0
3
7
3
5
3
6
1
6
6
0
.0
2
3
1
5
5
6
5
8
0
.0
1
3
4
1
6
6
0
.1
8
0
1
6
0
.0
1
2
T
0
6
5
6
ST
M
2
1
9
9
ci
rA
O
u
te
r
m
e
m
b
ra
n
e
b
.t
n
.d
.
n
.d
.
n
.d
.
n
.d
.
1
6
0
.1
3
9
T
1
2
6
6
ST
M
1
3
9
8
ss
eB
Se
cr
e
ti
o
n
ap
p
ar
at
u
s
n
e
e
d
le
n
.a
.
1
0
4
8
6
3
0
4
0
.0
1
6
3
2
9
6
1
4
3
0
.0
1
2
1
0
4
6
2
8
0
.0
0
6
4
1
0
6
1
7
0
,
0
.0
0
1
1
0
0
.1
0
4
T
1
2
6
9
ST
M
1
4
0
1
ss
eD
Se
cr
e
ti
o
n
ap
p
ar
at
u
s
tr
an
sl
o
co
n
n
.a
.
2
1
7
7
6
4
1
0
0
.0
0
3
8
2
3
6
3
5
7
0
.0
5
0
3
8
1
6
1
2
5
0
.0
3
1
2
0
2
6
8
5
,
0
.0
0
1
3
0
.1
6
2
1
,
t-
te
st
vs
.
n
o
n
-i
n
fe
ct
e
d
co
n
tr
o
l
m
ic
e
;
2
,
t-
te
st
o
f
lo
g
-t
ra
n
sf
o
rm
e
d
va
lu
e
s
vs
.
n
o
n
-i
n
fe
ct
e
d
co
n
tr
o
l
m
ic
e
;
3
,
lo
g
-r
an
k
te
st
vs
.
co
n
tr
o
l
m
ic
e
im
m
u
n
iz
e
d
w
it
h
G
FP
;
b
.t
.;
b
e
lo
w
q
u
an
ti
fi
ca
ti
o
n
th
re
sh
o
ld
;
n
.d
.,
n
o
t
d
e
te
rm
in
e
d
;
n
.a
.,
n
o
t
ap
p
lic
ab
le
fo
r
se
cr
e
te
d
p
ro
te
in
s
Ss
e
B
an
d
Ss
e
D
.
d
o
i:1
0
.1
3
7
1
/j
o
u
rn
al
.p
p
at
.1
0
0
2
9
6
6
.t
0
0
1
Identification of Salmonella Vaccine Antigens
PLOS Pathogens | www.plospathogens.org 4 October 2012 | Volume 8 | Issue 10 | e1002966
against a large number of in vivo expressed antigens from all
Salmonella compartments in agreement with data observed for S.
Typhi infected human patients [43]. There was no correlation
between in vivo antigen abundance as determined by proteome
analysis of ex vivo purified Salmonella, and CD4 T cell frequency or
cytokine profile (Tab. 1).
Serum antibody responses revealed similar broad recognition of
antigens from several Salmonella compartments (Fig. 1B) in
agreement with previous data for human typhoid fever patients
[24–26,44]. Interestingly, the three immunodominant humoral
antigens T2461, PhoN, and PcgL were all highly expressed in vivo
(Tab. 1) suggesting a potential impact of antigen dose on antibody
responses to Salmonella, although responses to minor antigens did
not correlate with antigen abundance. PhoN has been previously
recognized as an immunodominant antigen [26].
Immunization and challenge infection
Many of the tested Salmonella antigens were capable to induce
cellular and humoral immune responses. To test if these responses
could confer protective immunity, we tested the 21 recombinant
Salmonella antigens in immunization/challenge infection experi-
ments in genetically susceptible BALB/c mice. Based on the
results, we selected 16 additional Salmonella antigens primarily from
the outer membrane, and tested them using the same experimental
immunization/challenge approach (however, we did not measure
their immunogenicity in convalescent mice). For simplicity, we
discuss results for both antigen sets together. Out of 37 tested
antigens, only few antigens enabled prolonged survival after oral
challenge infection with virulent Salmonella compared to control
immunization with the unrelated antigen GFP (Fig. 2; Tab. 1;
poor survival of PhoN-vaccinated animals confirmed recently
published data [26]). In fact, only two antigens (T0937 and T2672)
mediated protective immune responses with P-values below 0.05
in our small experimental groups of only five mice per antigen.
Replicate experiments with larger group sizes might yield
statistical significant results for additional candidates such as SseB
that has already been shown to be protective in two independent
previous studies. Such experiments will be required to select
individual antigens for vaccine development in future studies. On
the other hand, the primary focus of this study was to identify
antigen properties that correlate with protectivity. For this
purpose, the somewhat noisy survival times detected with small
animal groups were still helpful.
As an example, survival times did not correlate with CD4 T cell
responses (Fig. 3A) or serum antibody levels (Fig. 3B) during
natural infection of resistant mice. This could partially reflect
differences in MHC class II haplotypes (H2d in BALB/c vs. H2b in
129/Sv), courses of infection, and potential differences in Salmonella
biology in susceptible vs. resistant mice. However, a recent large-
scale study reports comprehensive immunogenicity data for
BALB/c mice and other mouse strains that had been immunized
with attenuated Salmonella, as well as for human patients [26].
Several antigens that prolonged survival of immunized BALB/c
mice after Salmonella challenge infection in our experiments, elicit
detectable antibody responses in various mouse strains including
BALB/c. However, none of these antigens was found to be
immunodominant [26] and antibodies to antigens IroN and CirA
with the longest survival times were not detected in this and
previous studies. This could reflect differential antigen expression
in virulent vs. attenuated Salmonella, different routes of adminis-
tration, and/or differential expression at various stages of disease
progression. Together, these data provide no evidence for
immunodominance in convalescent or immune individuals as a
prerequisite for protectivity.
Figure 1. Cellular and humoral immune responses of convalescent Salmonella-infected mice to recombinant Salmonella antigens. A)
Antigen-specific CD4 T cell frequencies as detected by CD154 upregulation (red) and IFNc (green) or IL-17 (blue) secretion. The data represent means
6 SE of three mice. Responses to Salmonella antigens in non-infected control mice were subtracted (see also Fig. S1). B) Serum antibody responses to
Salmonella antigens. The data represent means 6 SE of 11 convalescent mice (filled circles) and means 6 SE for ten non-infected control mice (open
circles).
doi:10.1371/journal.ppat.1002966.g001
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Interestingly, in vivo expression levels also did not correlate with
survival times (Fig. 4A). In fact, the two antigens that enabled the
longest survival, IroN and CirA, had in vivo expression levels that
were below our detection threshold. By comparison, antigens
T2461 and PhoN were highly expressed in vivo and induced
potent CD4 T cell and humoral responses in convalescent
individuals, yet failed to prolong survival (in agreement with
previous observations [26]).
In contrast to immunogenicity and in vivo abundance, antigen
localization seemed to be crucial (Fig. 4B). In fact, antigens
enabling prolonged survival times were exclusively associated with
the Salmonella surface, either as experimentally validated outer
membrane-associated lipoproteins [45], as outer membrane
proteins, or as the translocon complex of the type III secretion
system encoded by Salmonella pathogenicity island two (SPI-2)
(Tab. 1). These data suggested distinct immune responses to
Salmonella outer membrane/surface antigens that fundamentally
differ from those to internal antigens.
On the other hand, surface localization alone was not sufficient
for protectivity. As examples, membrane proteins PgtE, PagC, and
Tsx were highly expressed in vivo and PgtE and PagC elicited
potent CD4 T cell responses in convalescent individuals (Fig. 1A).
PagC is also well recognized by antibodies and CD4 T cells of
human typhoid fever patients [24]. However, PagC, PgtE, and
Tsx failed to prolong survival. Interestingly, structural models
revealed that these proteins were largely buried in the outer
membrane bilayer (Fig. 5), and their extracellular loops contained
at most one predicted CD4 T cell epitope each, and only up to two
linear antibody epitopes, respectively. Importantly, key amino
acids in exposed T cell epitopes differed among Salmonella serovars
which might have impaired cross-protectivity of serovar Typhi
antigens against serovar Typhimurium challenge infection. Similar
observations were also made for non-protective TolC, OmpC,
OmpD, and OmpF. By contrast, antigens IroN, CirA, and FepA
that enabled extended survival after challenge infection, had
extracellular loops with several highly conserved T and B cell
epitopes (Fig. 5). Further studies with larger data sets will be
required to validate the relevance of these structural properties for
protectivity.
Impact of Salmonella antigen localization in an
ovalbumin model
The strong bias for surface-associated Salmonella antigens might
have been expected based on previous data for model antigens
suggesting superior immunogenicity of surface antigens compared
to internal antigens [30,46–50]. However, these model antigen
Figure 2. Survival curves of mouse groups immunized with 37 different Salmonella antigens (thin lines) or the control antigen GFP
(thick dashed line). For better visualization, curves were slightly shifted. The longest survival was observed for antigens IroN and CirA. For statistical
analysis by log-rank test see Table 1.
doi:10.1371/journal.ppat.1002966.g002
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Figure 3. Comparison of Salmonella antigen protectivity against primary infection and immunogenicity in convalescent resistant
mice. A) Relationship between antigen protectivity against primary infection and cognate CD4 T cell responses in convalescent mice (same data as
Fig. 1A). Protectivity is expressed as ‘‘survival time extension’’, which is the difference in median survival time of a group of five immunized mice
compared to a control group of five mice that were immunized with GFP. B) Relationship between antigen protectivity and serum antibody
responses in convalescent mice (same data as Fig. 1B).
doi:10.1371/journal.ppat.1002966.g003
Figure 4. Salmonella antigen protectivity does not correlate with in vivo antigen abundance but depends on antigen localization
within the Salmonella cell. A) Relationship between antigen protectivity and in vivo abundance as determined by quantitative proteome analysis
of ex vivo purified Salmonella (means6 SD for three independently infected mice; b.d., below detection threshold). B) Relationship between antigen
protectivity and antigen localization within Salmonella (C, cytosol; IM, inner membrane; P, periplasm; LP, outer-membrane associated lipoprotein;
OMP, outer membrane protein; S, surface). Statistical significance of differences between internal and outer membrane/surface antigens was tested
using the non-parametric Mann-Whitney U test.
doi:10.1371/journal.ppat.1002966.g004
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Figure 5. Structural models and exposed immune epitopes of various Salmonella outer membrane proteins. The outer membrane is
shown as a grey area, predicted CD4 T cell epitopes in exposed loops are shown in red, potential antibody binding sites are shown in blue, and
overlapping T and B cell epitopes are shown in magenta. Partially exposed epitopes are shown in pale colors. Amino acid residues that differ between
Salmonella enterica serovars Typhimurium and Typhi are shown in green. For TolC only the outer membrane-associated part is shown. LPS structures
as observed in FhuA-LPS crystals [93] are also shown.
doi:10.1371/journal.ppat.1002966.g005
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data were in striking contrast to results from us and others
demonstrating comparable immune responses to autologous
Salmonella antigens from all Salmonella compartments (Fig. 1A,B).
Furthermore, there was no obvious correlation between immuno-
genicity and survival times (Fig. 3A,B).
To better understand these discrepancies between model
antigens and autologous Salmonella antigens, we re-visited the
impact of antigen localization using a well-characterized, sensitive
model system in which a MHC II-restricted T cell epitope from
ovalbumin comprising amino acids 319 to 343 (OVA) is
recognized by adoptively transferred cognate T cell receptor
transgenic CD4 T cells [51,52]. We targeted the OVA epitope to
different Salmonella compartments by fusing it to various proteins
with known localization: GFP_OVA (cytosol [53]), OVA_MglB
(periplasm [54]), Lpp_OVA (inner leaflet of the outer membrane
[55]), and OVA_AIDA (outer leaflet of the outer membrane [56])
(Fig. 6A). To modulate expression levels, we used ribosome
binding sites with differential translation initiation efficiency [12].
We expressed these fusion proteins from an in vivo inducible
promoter [57] in an attenuated Salmonella enterica serovar
Typhimurium aroA strain [58]. Antigen expression and localization
was validated in in vitro cultures using cell fractionation followed
Figure 6. CD4 T cell responses to Salmonella expressing an ovalbumin model antigen in various compartments. A) Schematic overview
of fusion proteins that target an immunodominant ovalbumin epitope (OVA) to various Salmonella cell compartments. B) Flow cytometric analysis of
ovalbumin-specific CD4 T cell activation in a T cell receptor-transgenic adoptive transfer model. Mice were infected with control Salmonella
expressing GFP (left) or Salmonella expressing LPP_OVA (right). Ovalbumin-specific transgenic CD4 T cells were detected with a clonotypic
monoclonal antibody and analyzed for forward scatter and expression of the very early activation marker CD69. The dashed line was used to count
CD4 T cell blasts. Similar observations were made for more than hundred mice in several independent experiments. C) Relationship between
Salmonella Peyer’s patches colonization and OVA-specific CD4 T cell induction in mice infected with Salmonella expressing high levels of LPP_OVA
(filled circles) or low levels of GFP_OVA (open circles). Data represent means 6 SEM’s for groups of five to six animals from three independent
experiments. CD4 T cell blasts correlated with Salmonella Peyer’s patches colonization for both strains (Spearman test, P,0.05 in both cases). The
slopes of the two curves differed (ANCOVA; P,0.05). D) OVA-specific CD4 T cell induction in mice infected with Salmonella expressing OVA at various
levels (open circles, low abundance; filled circles, high abundance) in four different compartments. The dashed line represents CD4 T cell responses to
saturating levels of cytosolic OVA. The star represents data for Salmonella expressing moderate levels of cytosolic OVA together with cholera toxin B
and AIDA. Data represent means 6 SEM’s for groups of ten to twenty mice. Statistical significance of differences to Salmonella expressing saturating
levels of cytosolic OVA were tested using Mann-Whitney U test (*, P,0.05; **, P,0.01).
doi:10.1371/journal.ppat.1002966.g006
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by western blotting, trypsin treatment, and antibody binding (Fig. S2).
Interestingly, small fractions of both outer membrane antigens
LPP_OVA and partially processed OVA_AIDA were released to the
extracellular surroundings when expressed at high levels (Fig. S2C) in
agreement with previous findings for similar proteins [59–61].
We infected BALB/c mice with Salmonella strains by intragastric
gavage of 1010 CFU. All Salmonella strains colonized intestinal
Peyer’s patches with peak tissue loads of 36104 to 1.56105 CFU
at day seven post infection as observed before for attenuated
Salmonella aroA [62]. All constructs stably maintained their
respective ovalbumin-expression plasmids (.80% at 7 days post
infection). To determine antigen-specific CD4 T cell induction, we
adoptively transferred OVA-specific TCR-transgenic CD4 T cells
one day prior to Salmonella infection. OVA-specific T cells
upregulated the early activation marker CD69 and formed blasts
in mice infected with Salmonella expressing ovalbumin model
antigens, but not in mice infected with control Salmonella (Fig. 6B)
as observed previously [53]. CD4 T cell induction kinetics were
similar for all constructs and consistent with our previous
observations [53] suggesting a response to Salmonella in situ
antigen expression, but not to the inoculum [57,63].
To compare T cell responses against the various Salmonella
constructs, we measured T cell blast formation at peak Salmonella
colonization at day seven post infection. Salmonella tissue loads
varied somewhat between individual mice but for each construct,
there was a linear relationship between the number of ovalbumin-
specific DO11.10 blasts and Salmonella loads (Fig. 6C) in agreement
with our earlier observations [57]. To determine the specific
immunogenicity of each Salmonella strain, we calculated the
average ratio of DO11.10 CD4 T cell blasts per viable Salmonella
(i.e., the slopes in Fig. 6C) [57]. The data revealed comparable
immunogenicity of model antigens GFP_OVA and OVA_MglB
(Fig. 6D). In contrast, high-level expression of surface-associated
LPP_OVA and OVA_AIDA induced superior responses that
clearly surpassed responses even to saturating amounts [12] of
internal GFP_OVA.
The OVA_AIDA fusion protein contained a fragment of the
virulence factor AIDA from enteropathogenic E. coli and a cystein-
deficient variant of the cholera toxin B subunit from Vibrio cholerae
[64]. Both components might have stimulatory effects [65,66] that
could potentiate ovalbumin immunogenicity. To test this poten-
tially confounding factor, we compared Salmonella expressing a
suboptimal level of cytosolic GFP_OVA [12] (some 54.000 copies
per Salmonella cell) to Salmonella expressing the same amount of
GFP_OVA together with AIDA and cholera toxin B. Both strains
induced DO11.10 T cell blasts with similar efficacy (Fig. 6D)
Figure 7. Detection of intact and damaged Salmonella cells in infected mouse tissues. A) Flow cytometry of a spleen homogenate infected
with Salmonella sifB::gfp using 488 nm excitation. Gate 1 contains GFP-positive Salmonella. The inset shows the relationship between flow cytometry
data and plate counts for individual mice, the dashed line represents a 1:1 ratio. B) Confocal micrographs of liver cryosections infected with
Salmonella sifB::gfp that were stained with antibodies to Salmonella lipopolysaccharide (red) and macrophage marker CD68 (blue). Individual color
channels are shown with inverted grey scale for better visualization of weak staining. Micrographs represent typical observations for four
independently infected mice. C) Confocal micrographs of lipopolysaccharide-positive particles that lack detectable GFP (even when contrast was
increased compared to B). Such particles were absent in non-infected control sections.
doi:10.1371/journal.ppat.1002966.g007
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suggesting that AIDA and cholera toxin B expression had no
impact on the immunogenicity of Salmonella-encoded OVA.
Taken together, these findings suggested that antigens from all
Salmonella compartments could induce specific CD4 T cell
responses, but highly expressed outer membrane-associated
antigens were clearly superior in agreement with previous
observations in other model systems. However, these data were
in striking contrast to responses to autologous Salmonella antigens
(see discussion).
Distribution of intact and damaged Salmonella in
infected tissues
The fundamentally superior protectivity of surface-associated
Salmonella antigens might reflect their unique accessibility to
antigen processing and presentation in infected host cells in
contrast to internal Salmonella antigens that are shielded by the
Salmonella envelope, and thus remain invisible for the host immune
system until Salmonella is damaged and the bacterial cell breaks
open. To detect intact and damaged Salmonella in infected tissues,
we used cytosolic GFP as a marker for internal antigens.
Salmonella expressing GFP from the chromosomal in vivo
induced locus sifB were readily detected in infected tissue
homogenates using flow cytometry [12] (Fig. 7A). Flow cytometric
counts for GFP+ Salmonella closely correlated with viable counts as
determined by plating (Fig. 7A, inset) suggesting that detectable
GFP levels were present in all live Salmonella.
Confocal microscopy of infected spleen and liver sections
revealed many particles that were stained by a polyclonal antibody
to Salmonella lipopolysaccharide, had typical Salmonella size and
morphology, and contained GFP (Fig. 7B) as previously observed
[53] suggesting that these particles represented live intact
Salmonella. In addition, we also detected numerous lipopolysac-
charide-positive particles with distorted shapes that lacked
detectable GFP (Fig. 7C), and likely represented killed and
partially degraded Salmonella. Such particles were absent in non-
infected control sections. Some Salmonella killing during acute
infections had previously been proposed [67–69]. We observed
some infected cells containing both intact and damaged Salmonella,
but a large number of live Salmonella resided alone (or together with
other live Salmonella) in infected cells with no detectable dead
Salmonella. In such infected cells, internal Salmonella antigens were
thus shielded and inaccessible for immune recognition.
Discussion
There is an urgent medical need for an efficacious Salmonella
vaccine with broad coverage of invasive serovars. One important
bottleneck in the development of such a vaccine is the
identification of suitable protective antigens. In this study, we
identified broadly conserved S. Typhi antigen candidates that
prolonged survival after S. Typhimurium challenge infection in the
mouse typhoid fever model. The protectivity of some of these
candidates should be confirmed with larger experimental groups
to select the best antigen candidates for vaccine development in
future studies.
Two siderophore receptors (IroN, CirA) enabled the longest
survival (Tab. 1) consistent with previous studies that revealed
siderophore receptors including IroN as promising vaccine
antigens in other models [70–72]. Interestingly, siderophore
receptors are induced by iron starvation and/or activation of the
PhoPQ two component sensory system [73]. IroN and CirA
induction could thus contribute to increased protective efficacy of
membrane preparations from iron-starved Salmonella [74], or live
attenuated Salmonella phoQ24 with constitutive hyperactivation of
the PhoP response regulator [75].
On the other hand, all identified antigens still provided at most
partial protection against challenge infection with virulent
Salmonella suggesting a need for additional antigens. Unfortunately,
protective Salmonella antigens might be rather rare as even among
the 37 tested in vivo expressed antigens that were all highly
immunogenic during infection, only a small minority enabled
prolonged survival. OmpC, OmpD, and OmpF were previously
proposed as potential protective antigens based on data obtained
for enriched Salmonella membrane preparations. However, all three
antigens failed to protect in our model. This could reflect higher
stringency of our model (challenge infection with virulent
Salmonella vs. highly attenuated mutant Salmonella), denatured
three-dimensional structures of our recombinant antigen prepara-
tions vs. native antigens, and/or presence of undetected minor
protective antigens (such as IroN and CirA) besides OmpC,
OmpD, and OmpF in the previously used outer membrane
antigen preparations.
Additional protective Salmonella antigens could be identified by
comprehensive immunization/challenge experiments, but this
would require extensive animal experimentation. Antigen prior-
ization using relevant antigen properties could help to narrow
down the number of antigen candidates to more practical
numbers. Unfortunately, some previously proposed antigen
properties seemed to have limited relevance for protectivity in
our model. This included Salmonella in vivo expression levels,
sequence-based antigenicity predictions, and immunodominance
in convalescent individuals. Poor correlation of antigen immuno-
dominance with protective efficacy has also been observed in
tuberculosis [17]. On the other hand, immune recognition in
convalescent individuals can still provide valuable information
about antigen expression during at least some stage of infection
that might be difficult to obtain otherwise [23,29]. Such data thus
could greatly help to prioritize antigen candidates [26].
In contrast to antigen abundance and immunodominance,
surface-association appeared to be an essential prerequisite.
Surprisingly, some surface-associated proteins that enabled pro-
longed survival also included lipoproteins which were likely to
reside in the inner leaflet of the outer membrane facing the
internal periplasmic space with no exposure to the outside. It is
possible that some lipoproteins might flip across the outer
membrane as observed for other Gram-negative bacteria [76].
Moreover, some lipoprotein fraction is constantly released to the
outside through outer membrane vesicle shedding [59,60].
Several mechanisms could contribute to the striking superiority
of surface-associated antigens. Antibody responses are important
for full protection against virulent Salmonella [10], and protective
antibody responses must be directed against surface antigens [9].
On the other hand, CD4 T cells are even more important for
immunity to Salmonella at least in the mouse typhoid fever model
[10], and it is unclear why CD4 T cells should respond to surface-
associated antigens in a fundamentally different way compared to
the much larger number of internal antigens.
In fact, early cell culture experiments suggested no impact of
Salmonella antigen localization on CD4 T cell recognition of
infected cells [77]. However, in this study a large amount of
antigen was already present in the inoculum, and rapid killing of
the majority of phagocytosed Salmonella [78] would have released
this antigen from all Salmonella compartments. Several subsequent
in vivo studies suggested that surface-associated model antigens
might have intrinsically higher immunogenicity compared to
internal model antigens [30,46–50]. However, the various model
antigen targeting constructs could have differed in antigen in vivo
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expression levels, antigen stability, and epitope processing. Fusion
partners could also have direct immunomodulatory effects. We
therefore re-visited this issue and tried to control some of these
factors. Our results clearly supported the previous finding of
superior immunogenicity of highly expressed surface-associated
model antigens in Salmonella.
In surprising contrast to these data from model antigens,
however, humoral and cellular immune responses in Salmonella-
infected convalescent mice did not show any bias for surface-
associated autologous Salmonella antigens in this as well as in a
recent large-scale study [26]. Broad recognition of antigens from
all pathogens compartments has also been observed in Salmonella
Typhi-infected or Chlamydia-infected human patients
[24,25,29,43,44]. Model antigens and autologous antigens were
also discordant with respect to the impact of antigen abundance.
Specifically, our data for ovalbumin model antigens in this and a
previous study [12], as well as similar findings for Mycobacterium
bovis BCG overexpressing Ag85b [19], suggested that high in vivo
expression levels enhance antigen immunogenicity. However, for
autologous Salmonella antigens in vivo expression levels did not
correlate with protectivity. Striking discrepancies between results
for model antigens vs. autologous antigens have also been
observed in other pathogens [38].
Some of the discrepancies could reflect technical issues. In
particular, strong expression of foreign surface model antigens
might induce subtle alteration in Salmonella in vivo properties such
as increasing outer membrane vesicle shedding or alterations in
protein secretion that could affect antigen presentation and
immune recognition. Furthermore, model antigens might not be
representative of autologous antigens that may have been shaped
by host/pathogen co-evolution selecting for weak immunogenicity.
Regardless of the actual causes of these discrepancies, our data
indicated that in contrast to evidence from model antigens,
protective Salmonella surface-associated antigens were not more
immunogenic compared to internal antigens.
As an alternative explanation, surface-associated antigens might
become more rapidly available for immune recognition compared
to internal antigens that are only released after some pathogen
damage. This could be relevant since early immune responses
might facilitate infection control [32]. In the mouse typhoid fever
model, however, a detectable fraction of Salmonella is rapidly killed
early during infection as observed in this and previous studies
[67,69] similar to events during Mycobacterium infection [79].
Consistent with these observations, CD4 T cell induction kinetics
in the ovalbumin model system were similar for Salmonella strains
with internal or surface-associated OVA-expression.
Instead, we propose an alternative explanation based on the
observation that many live Salmonella resided alone, or together
with other live Salmonella, in infected host cells with no dead
Salmonella releasing their internal antigens. As a consequence,
Figure 8. Schematic model for cellular immunity to Salmonella. Salmonella (yellow) reside in intracellular vacuoles in infected host cells.
Salmonella possesses internal (green) and surface-associated (red) antigens. Left) Live Salmonella shield internal antigens, but some of their surface-
associated antigens are accessible for processing and presentation. As a consequence, T cells specific for Salmonella surface antigens can recognize
these infected cells and initiate antibacterial immune effector mechanisms. In contrast, T cells specific for internal Salmonella antigens fail to detect
host cells that contain exclusively intact Salmonella. Right) Dead Salmonella release internal antigens. As a consequence, both surface-exposed and
internal antigens can be processed, presented, and recognized by cognate T cells. However, this recognition is unproductive for infection control
since it targets Salmonella that are already dead.
doi:10.1371/journal.ppat.1002966.g008
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Salmonella internal antigens remained inaccessible for antigen
processing and presentation in these cells. In contrast, surface-
exposed Salmonella antigens, or antigens released by outer
membrane vesicle shedding, could be accessible for processing
and presentation to cognate CD4 T cells for initiation of protective
anti-Salmonella effector mechanisms (Fig. 8). In comparison, CD4 T
cells recognizing internal Salmonella antigens would have limited
impact on infection control because they miss many cells
containing live Salmonella and instead direct their responses to
host cells containing already dead Salmonella. According to this
model, surface-associated antigens thus differ fundamentally from
internal antigens because they are uniquely accessible in host cells
containing only live Salmonella.
Surface-associated/secreted antigens have been shown to be
crucial for CD8 T cell-dependent immunity to Listeria infection
[31,33]. Our data suggested that such antigens might also be
crucial for CD4 T cell mediated immunity to Salmonella and
potentially other intracellular pathogens. Interestingly, some
internal antigens have been shown to confer partial protection in
infectious diseases caused by intracellular pathogens such as
Leishmania [38] and Mycobacterium [37]. In these infections live and
dead pathogens often co-occur in the same host microenviron-
ments [80,81] suggesting that both internal and surface-associated
antigens might be available for T cell recognition and initiation of
antimicrobial immune effector mechanisms targeting both live and
already dead pathogens [82]. We speculate that full protection
might still require immune detection of all live pathogens including
those that reside in microenvironments with yet no accessible
internal antigens from dead pathogens. Further studies are
required to test this hypothesis.
Conclusion
This study suggested novel Salmonella antigens that conferred
partial protection against virulent Salmonella in a stringent typhoid
fever model. High sequence conservation among relevant Salmo-
nella serovars and cross-protection of serovar Typhi antigens
against serovar Typhimurium challenge infection, suggested that
some of these antigens might help to pave the way for a broadly
protective vaccine against systemic Salmonella infection. In addi-
tion, our findings suggested that surface-associated antigens might
represent particular promising antigens for both humoral and
cellular immunity to Salmonella, since recognition of surface
antigens uniquely enables detection and destruction of live
Salmonella in relevant host microenvironments. This crucial
importance of antigen localization could facilitate discovery of
additional protective antigens for Salmonella and potentially other
intracellular pathogens.
Materials and Methods
Ethics statement
All animal experiments were approved (license 2239, Kanto-
nales Veterina¨ramt Basel-Stadt) and performed according to local
guidelines (TschV, Basel) and the Swiss animal protection law
(TschG).
Cloning, expression, and purification of Salmonella
antigens
Antigens were PCR-amplified from Salmonella enterica serovar
Typhi Ty2 (or Salmonella enterica serovar Typhimurium SL1344
[58] for ompD), cloned as His6-fusions by conventional ligation into
pET22b, or by Enzyme Free Cloning into plasmid pLICHIS [83],
and overexpressed in E. coli BL21. GFP_His6 was cloned as
control antigen. Antigens were purified from washed inclusion
bodies using immobilized metal ion affinity chromatography
(Protino Ni TED 1000, Macherey Nagel) followed by ion
exchange chromatography (Ion exchange spin columns, Pierce
Thermo Scientific, cationic or anionic resins depending on antigen
isoelectric point).
Proteome analysis of ex vivo sorted Salmonella
Salmonella expressing the green fluorescent protein (GFP) were
sorted infected using flow cytometry as described [22]. Preparation
of tryptic peptides and analysis by LC-MS/MS was done essentially
as described [84] with some modifications. Given the limited sample
material Protein LoBind tubes and pipette tips (Axygen) were used
throughout the procedure. Frozen FACS sorted Salmonella pellets
were resuspended in 15 ml lysis buffer (100 mM ammonium
bicarbonate, 8 M urea, 0.1% RapiGest) and sonicated for
2630 seconds. The released proteins were reduced and alkylated,
and first digested for 4 hrs with sequencing grade LysC peptidase
(10 ng/ml; Promega) before overnight trypsin digestion. The
detergent was cleaved by adding 2M HCL and 5% TFA to final
concentrations of 50 mM and 0.5% respectively, and incubating for
45 min at 37uC. Prior to centrifugation to remove the cleaved
detergent (14,0006g, 10 min, 4uC) a mixture containing 32 heavy
labeled reference peptides were added to the samples (5*1025
fmoles per Salmonella for expected ‘‘high’’ abundance proteins,
5*1026 fmoles per Salmonella for expected ‘‘low’’ abundance
proteins; Tab. S1). The recovered peptides were desalted on C18
reverse-phase spin columns (Macrospin columns, Harvard appara-
tus), dried under vacuum and subjected to LC-MS/MS using an
LTQ-Orbitrap-Velos instrument (Thermo-Fischer Scientific). The
amount of material analyzed in a single shot in the MS depended on
the infection load, and corresponded to peptides derived from
between 5*105 and 2*106 sorted Salmonella, plus contaminating
mouse material which escaped detection in the cell sorter [22]. We
analyzed samples from seven independently infected mice. In order
to increase the number of Salmonella protein identifications, MS-
sequencing was focused on previously identified peptides from
Salmonella using the recently developed inclusion list driven workflow
[84]. Each sample was analyzed twice in succession in the MS to
verify technical reproducibility. Peptides and proteins were database
searched against a decoy database consisting of the SL1344 genome
sequence (ftp://ftp.sanger.ac.uk/pub/pathogens/Salmonella/),
GFP_OVA, 204 frequently observed contaminants, all mouse
entries from SwissProt (Version 57.12), and all sequences in reversed
order (total 42502 entries) using the Mascot search algorithm. The
search criteria were set as follows: full tryptic specificity was required
(cleavage after lysine or arginine residues); 2 missed cleavages were
allowed; carbamidomethylation (C) was set as fixed modification;
oxidation (M) as variable modification. The mass tolerance was set
to 10 ppm for precursor ions and 0.5 Da for fragment ions. The
false discovery rate was set to 1% for protein and peptide
identifications. In addition to Salmonella proteins a substantial
number of mouse proteins were identified in the samples as
previously noted [22]. Absolute quantities were determined for
those 18–20 ‘‘anchor’’ proteins that were detected along with a
corresponding labeled AQUA peptide using the Trans-Proteomic
Pipeline (TPP,V4.4.0). We then used the iBAQ method [40] to
establish absolute quantities of all remaining protein identifications,
with a linear model error of between 47 and 60%.
Construction of ovalbumin-expressing Salmonella
Translational fusions of the ovalbumin peptide containing
amino acids 319 to 343 to various proteins with differential
targeting in the Salmonella cell were constructed by PCR cloning.
All fusion genes were cloned into a pBR322-derived plasmid
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backbone [53] downstream of a Salmonella genome fragment
containing the in vivo inducible pagC promoter [57] and ribosomal
binding site 1 (AAGAA) or 2 (AGCAG) for low or high translation
initiation efficiencies [12]. To generate ova_aida, coding sequence
for the ovalbumin peptide (ova) was inserted between the signal
peptide derived from cholera toxin B and the HA tag in plasmid
pLAT260 [85]. A control plasmid coding for CTB_AIDA and
GFP_OVA was also constructed. To generate lpp_ova, lpp without
the C-terminal lysine codon that can cross-link to peptidoglycan
[86], was amplified from E. coli DH5a and fused with ova and a C-
terminal HA tag. To generate ova_mglB, mglB gene without the
signal peptide sequence was amplified from E. coli DH5a and fused
with a ctB signal sequence followed by ova and the HA tag. The
construction of gfp_ova has been described [87]. The various
plasmids were transformed into attenuated Salmonella enterica
serovar Typhimurium aroA SL3261 [58].
Biochemical analysis
Ovalbumin expression was assessed by western blotting with a
polyclonal antibody to ovalbumin (Sigma) that recognizes the OVA
peptide comprising amino acids 319 to 343 [53]. Salmonella outer
membranes were prepared by extraction with L-lauryl sarcosinate
as described [85]. Periplasm was prepared by chloroform extraction
as described [88]. Culture supernatants were sterile filtered (0,2 mm
pore size) and subjected to TCA precipitation [89]. To assess
ovalbumin surface accessibility, intact or lysed Salmonella cells were
treated with 50 mg ml21 trypsin at 37uC for 10 min. In addition,
Salmonella were stained with an antibody to the HA tag, and
examined by fluorescence microscopy.
Immune responses in convalescent mice
Female 8 to 12 weeks old 129/Sv mice were obtained from
Charles River. Mice were orally infected with 109 CFU Salmonella
enterica serovar Typhimurium SL1344 [58] from late log cultures
using a round-tip stainless steel needle. Control mice were sham-
infected. Mice were sacrificed 6 months after infection. Splenocytes
were isolated and tested for antigen-specific CD4 T cell responses as
described [41]. Unstimulated T cells from convalescent mice as well
as antigen-stimulated T cells from naı¨ve control mice showed only
weak background responses (Fig. S1). Some antigens gave also weak
responses for T cells from convalescent mice (depending on the
individual mouse). Together, these data suggested that antigen-
nonspecific background responses to E. coli contaminants that might
have been present in trace amounts in our antigen preparations did
not result in unspecific T cell responses in our assay. Plasma was
tested for antigen-specific IgG responses using ELISA with an IgG
calibration curve for absolute quantification.
Immunization and challenge experiments
Female, 8 to 12 weeks old BALB/c mice were obtained from
Charles River. Groups of 5 mice were immunized subcutaneously
with 10 mg antigen emulsified in complete Freund’s adjuvant
followed by a second immunization with incomplete Freund’s
adjuvant four weeks later. After additional four weeks, mice were
orally infected with 66105 CFU Salmonella enterica serovar
Typhimurium SL1344 [58] from late log cultures using a round-
tip stainless steel needle. Infected BALB/c were monitored twice
daily and sacrificed when moribund.
Ovalbumin-specific CD4 T cell responses
BALB/c and DO11.10 mice [51] were bred in the Bundesamt
fu¨r gesundheitlichen Verbraucherschutz und Veterina¨rmedizin
(Berlin, Germany) under specific-pathogen free conditions. Adop-
tive transfer of 46106 DO11.10 T cells into syngenic age- and sex-
matched BALB/c mice was performed one day before infection as
described [53]. For infection, attenuated Salmonella strains carrying
expression cassettes for various ovalbumin fusion proteins were
grown to late log phase and harvested. Bacteria were washed twice
and resuspended in LB containing 3% sodium bicarbonate. Doses
containing ca. 1010 cfu in 100 ml were administered intragastri-
cally to chimeric mice with a round-tip stainless steel needle. At
various time points post infection, mice were anesthetized and
sacrificed. DO11.10 T cell blast formation was determined by flow
cytometry as described [53]. Aliquots of the same Peyer’s patch
preparations were treated with 0.1% Triton x-100 to release
intracellular Salmonella for CFU determination by plating, and for
quantitation of GFP_OVA in vivo expression levels by two-color
flow cytometry as described [87]. Many TCR tg models show
substantial clonal expansion upon antigen stimulation. However,
in our Salmonella model we observe only weak and variable
accumulation of tg CD4 T cells in infected tissues which might
reflect the fact that even at peak Salmonella loads only about 1 ng
antigen is present [87]. Instead, blastogenesis as measured by
CD69 upregulation and increased forward scatter provides a
sensitive antigen-specific readout.
Detection of intact Salmonella in infected tissues
BALB/c mice with Salmonella loads of 106 to 107 in spleen and
liver were sacrificed. 10 mm cryosections were stained with
polyclonal rabbit antibodies to Salmonella lipopolysaccharide
(SIFIN) and anti-CD68 (abcam) followed by Alexa 546-conjugated
goat anti-rabbit and Alexa 647-conjugated goat anti-rat antibodies
(Invitrogen). Sections were examined by confocal microscopy
(Leica, SP5).
Structural models and epitope prediction
Structural models for selected Salmonella outer membrane
antigens based on solved structures of homologues were obtained
from SWISS-MODEL [90] available at http://swissmodel.expasy.
org. Linear B-cell epitopes were predicted using FBCPred [91]
available at http://ailab.cs.iastate.edu/bcpreds/predict.html using
an epitope length of 14 and 90% specificity. Peptides that bind to
MHC II I-Ad and/or I-Ed were predicted using RANKPEP [92]
available at http://imed.med.ucm.es/Tools/rankpep.html with a
binding threshold yielding 85% sensitivity for detection of well-
defined epitopes in MHCII haplotype databases (the default
setting of RANKPEP).
Supporting Information
Figure S1 Representative antigen-specific CD4 T cell
responses in convalescent and control mice. Cells were
stimulated with various antigens (shown are examples for T2461 and
T0937). CD4, CD154-double positive cells representing responding
cells were gated (upper panels) and analyzed for IFNc and IL-17
(lower panels). Background responses in control mice were subtracted
form responses in convalescent mice and reported in Tab. 1.
(TIF)
Figure S2 Expression and localization of ovalbumin
epitope fusion proteins in Salmonella. A) Anti-ovalbumin
immunoblot of total Salmonella cell lysates (36107 cfu) of strains
expressing either low (‘‘lo’’) or high (‘‘hi’’) levels of ovalbumin fused
to different proteins. Expected molecular weights were: GFP_OVA,
30 kDa; OVA_MglB, 38 kDa; Lpp_OVA, 11 kDa; OVA_AIDA,
67 kDa. B) Localization of various fusion proteins. OVA_MglB was
detected in isolated periplasm fractions (Ppl.) in similar quantities as
in whole cell lysates (Lys.). Lpp_OVA was detected in isolated outer
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membrane fractions. It was unaccessible for trypsin degradation in
intact Salmonella but readily digestible in isolated membrane
fractions. Immunostaining of intact Salmonella with a fluorescent
antibody showed no detectable signal. OVA_AIDA was detected in
isolated outer membranes and accessible to trypsin digestion even in
intact Salmonella suggesting surface localization. This was confirmed
by immunostaining. C) Immunoblot of culture supernatants of
4.561011 CFU (TCA precipitation). Endogenous Salmonella pro-
teins with apparent molecular weights of ca. 23 and 67 kDa,
respectively, cross-react with the anti-ovalbumin polyclonal anti-
body (empty arrowheads). These bands were also detected in non-
recombinant Salmonella. In addition, an OVA-containing protein of
around 11 kDa was released from Lpp_OVA expressing Salmonella
(black arrowhead), whereas a 30 kDa fragment was released from
Salmonella expressing high amounts of OVA_AIDA.
(TIF)
Table S1 List of isotope labeled peptides used for
protein quantification.
(XLS)
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